Dietary interventions that reduce ultra-processed food intake and prioritize minimally processed nutrient-dense foods may represent a feasible, low-risk strategy to support mental health by restoring lipid balance and reducing neuroinflammatory burden
Growing preference for orally administered therapies over injectable formulations is a key factor supporting market expansion, as oral medications improve treatment adherence, patient convenience, and long-term therapy compliance
( the lotion is an amazing peppermint infused one that I LOVE when getting my massage)
Rare but serious risks include pancreatitis and gallbladder disease
The Chief Scientific Advisor at Novo Nordisk, Lotte Bjerre Knudsen, was the key force who pushed hard to develop GLP-1 drugs for treating obesity and subsequently for Alzheimers
Observational data presented at ASCO 2026 suggested an association between GLP-1 use and lower metastatic progression in obesity-related cancers, including breast cancer